TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 2 | 1 | 0 | -12 | -9 | -5 | 3 | -4 |
| S | %wins | 50 | 50 | 100 | 100 | 50 | 50 | 67 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/1/11 15:06 | 2/28/11 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Kazmi Syed | CA | O | VP,Bus. | S | -12 | 10.69 | 1 | -1 | -8 | 14 | D | -33 | 1 | 17 | 29 | 19 | 21 | 6 | 9 | -1 | -2 | -8 | -2 | 15 | 36 |
12/24/09 13:33 | 12/24/09 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Kazmi Syed | CA | O | VP,Bus. | S | -4 | 2.15 | 0 | -2 | -3 | 58 | D | -63 | -17 | -26 | -10 | 6 | 13 | 10 | 11 | 3 | 2 | -16 | -16 | -25 | -30 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |